Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Damaj

Showing results (41-50 of 56) with videos related to

Pageof 6
Sort By:
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2014
Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot studyJ Paccou, L Merlusca, I Henry-Desailly, et al.
Allergy|February 4, 2016
Decreased tryptophan and increased kynurenine levels in mastocytosis associated with digestive symptomsS Georgin-Lavialle, J-M Launay, F Côté, et al.
Bone Marrow Transplantation|March 7, 2006
The VAD chemotherapy regimen plus a G-CSF dose of 10 microg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 microg/kg for progenitor cell mobilization: results from a monocentric study of 82 patientsF Lefrère, S Zohar, D Ghez, et al.
Bone Marrow Transplantation|May 11, 2004
Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantationM Mohty, J M Boiron, G Damaj, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature reviewG Damaj, V Verkarre, A Delmer, et al.
Bone Marrow Transplantation|May 21, 2013
Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCTA J Innes, R Beattie, R Sergeant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2013
Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSAA Trebouet, T Marchand, R Lemal, et al.
Leukemia|April 18, 2002
Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective studyF Lefrère, A Delmer, F Suzan, et al.
Leukemia|January 20, 2009
Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 casesR Itzykson, S Ayari, D Vassilief, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantationI Yakoub-Agha, P de La Salmonière, P Ribaud, et al.
Pageof 6

Showing results (41-50 of 56) with videos related to

Sort By:
Pageof 6
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 10, 2014
Alterations in bone mineral density and bone turnover markers in newly diagnosed adults with lymphoma receiving chemotherapy: a 1-year prospective pilot studyJ Paccou, L Merlusca, I Henry-Desailly, et al.
Allergy|February 4, 2016
Decreased tryptophan and increased kynurenine levels in mastocytosis associated with digestive symptomsS Georgin-Lavialle, J-M Launay, F Côté, et al.
Bone Marrow Transplantation|March 7, 2006
The VAD chemotherapy regimen plus a G-CSF dose of 10 microg/kg is as effective and less toxic than high-dose cyclophosphamide plus a G-CSF dose of 5 microg/kg for progenitor cell mobilization: results from a monocentric study of 82 patientsF Lefrère, S Zohar, D Ghez, et al.
Bone Marrow Transplantation|May 11, 2004
Graft-versus-myeloma effect following antithymocyte globulin-based reduced intensity conditioning allogeneic stem cell transplantationM Mohty, J M Boiron, G Damaj, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 22, 2003
Primary follicular lymphoma of the gastrointestinal tract: a study of 25 cases and a literature reviewG Damaj, V Verkarre, A Delmer, et al.
Bone Marrow Transplantation|May 21, 2013
Escalating-dose HLA-mismatched DLI is safe for the treatment of leukaemia relapse following alemtuzumab-based myeloablative allo-SCTA J Innes, R Beattie, R Sergeant, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|August 24, 2013
Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSAA Trebouet, T Marchand, R Lemal, et al.
Leukemia|April 18, 2002
Sequential chemotherapy by CHOP and DHAP regimens followed by high-dose therapy with stem cell transplantation induces a high rate of complete response and improves event-free survival in mantle cell lymphoma: a prospective studyF Lefrère, A Delmer, F Suzan, et al.
Leukemia|January 20, 2009
Is there a role for all-trans retinoic acid in combination with recombinant erythropoetin in myelodysplastic syndromes? A report on 59 casesR Itzykson, S Ayari, D Vassilief, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2000
Allogeneic bone marrow transplantation for therapy-related myelodysplastic syndrome and acute myeloid leukemia: a long-term study of 70 patients-report of the French society of bone marrow transplantationI Yakoub-Agha, P de La Salmonière, P Ribaud, et al.
Pageof 6